51
|
Koch B, Tannapfel A, Vieth M, Grün R. [Gastric metastasis from small cell lung cancer]. Pneumologie 2009; 63:585-7. [PMID: 19708008 DOI: 10.1055/s-0029-1214905] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Small cell carcinomas are most frequently localised within the lung, however, they also may be detected at extrapulmonary sites such as the gastrointestinal tract and the genitourinary tract. The confirmation of a small cell carcinoma outside of the lung may not necessarily indicate the presence of a metastasis, however, it also may represent the primary tumor itself. We present the case of a patient with a small cell carcinoma of the lung with metastases to the stomach. A regression of the primary lung tumor and the disappearance of the gastric metastases could be achieved by chemotherapeutic treatment with carboplatin, etoposide, and vincristine. However, death due to pneumonia occurred 3 months after initial diagnosis. This case illustrates that in rare cases a metastasis from small cell lung cancer may occur in the intestinal tract even without leading to distinctive symptoms.
Collapse
|
52
|
Kappler G, Kälber S, Koch B, Leible L. Stroh und Waldrestholz - Ergebnisse einer Standortanalyse für Bioenergieanlagen in Baden-Württemberg. CHEM-ING-TECH 2009. [DOI: 10.1002/cite.200950345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
53
|
Koch B, Schaper C, Volzke H, Ewert R, Glaser S. From the authors:. Eur Respir J 2009. [DOI: 10.1183/09031936.00048109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
54
|
Glaser S, Schaper C, Ewert R, Koch B. Peak oxygen uptake and exercise capacity: a reliable predictor of quality of life? Eur Heart J 2009; 30:1674; author reply 1674-5. [DOI: 10.1093/eurheartj/ehp208] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
55
|
Koch B, Ewert R, Gläser S. Iatrogenic arteriovenous fistula causing pulmonal arterial hypertension and right heart failure. Pneumologie 2009. [DOI: 10.1055/s-0029-1214080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
56
|
Koch B, Schäper C, Ittermann T, Spielhagen T, Dörr M, Völzke H, Opitz C, Ewert R, Gläser S. Reference Values for Cardiopulmonary Exercise Testing in Obese Individuals – Results from the SHIP Study. Pneumologie 2009. [DOI: 10.1055/s-0029-1213993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
57
|
Schnell M, Jantzen F, Koch B, Gläser S, Schäper C, Felix S, Ewert R, Landsberger M. ET-1-induzierte Expression von LOX-1 in Fibroblasten und venösen Endothelzellen der Lunge: Effekte von Bosentan in vitro. Pneumologie 2009. [DOI: 10.1055/s-0029-1214128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
58
|
Lackner C, Wendt M, Ahnefeld F, Koch B. Von der Rettungskette zum akutmedizinischen Netzwerk. Notf Rett Med 2009. [DOI: 10.1007/s10049-008-1114-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
59
|
Schäper C, Gustavus B, Koch B, Ewert R, Hanf G, Kunkel G, Noga O, Gläser S. Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis. J Investig Allergol Clin Immunol 2009; 19:459-464. [PMID: 20128420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023] Open
Abstract
OBJECTIVE Allergic rhinitis, a disease that impairs quality of life, is characterized by inflammation due to an allergic reaction. Fexofenadine is a second-generation histamine receptor blocker well known for its potent interaction with this inflammatory process. The main aim of this study was to further clarify the anti-inflammatory effects exerted by fexofenadine in patients with intermittent allergic rhinitis. METHODS Twenty patients with intermittent allergic rhinitis due to birch and mugwort pollen were enrolled. Fexofenadine was administered once a day at a dose of 120 mg. Clinical improvement was assessed by a symptom score, and nasal airway flows were measured by anterior rhinomanometry at baseline and after 2 weeks of treatment with fexofenadine. Nasal smears were tested for eosinophils and nasal lavage fluid were examined for histamine, cysteinyl leukotrienes, soluble intercellular adhesion molecule-1, eosinophil cationic protein, and albumin by enzyme-linked immunosorbent assay. All the tests were performed during the pollen season. RESULTS Fexofenadine induced a significant improvement in nasal and ocular symptoms (P < .001), nasal edema and secretion (P < .001), and nasal airway flow (P < .001). The clinical improvement was related to a significant reduction in all inflammatory mediators (P < .01 in all cases). CONCLUSION This study demonstrates that fexofenadine is able to mediate significant changes in different nasal lavage markers from patients with intermittent allergic rhinitis. The changes observed in the markers analyzed in both nasal secretions and serum are attributable to the anti-inflammatory effects of fexofenadine in vivo.
Collapse
|
60
|
Kleber M, Ihorst G, Deschler B, Wider D, Jakob C, Liebisch P, Koch B, Engelhardt M. Detection of renal impairment (RI) as one specific comorbidity (CM) factor in multiple myeloma (MM) patients (pts): analysis in consecutive MM pts within a multicenter study. Crit Rev Oncol Hematol 2008. [DOI: 10.1016/s1040-8428(08)70111-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
61
|
Koch B, Schaper C, Ittermann T, Spielhagen T, Dorr M, Volzke H, Opitz CF, Ewert R, Glaser S. Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study. Eur Respir J 2008; 33:389-97. [DOI: 10.1183/09031936.00074208] [Citation(s) in RCA: 117] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
62
|
Vogel M, Herbers C, Koch B. Effects of Salt and Nanoparticles on the Segmental Motion of Poly(ethylene oxide) in Its Crystalline and Amorphous Phases: 2H and 7Li NMR Studies. J Phys Chem B 2008; 112:11217-26. [DOI: 10.1021/jp801775u] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
63
|
Koch B, Gerzer R. A research facility for habitation questions to be built at the German Aerospace Center in Cologne: future challenges of Space medicine. Hippokratia 2008; 12 Suppl 1:91-96. [PMID: 19048099 PMCID: PMC2577409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
For long term habitation in space and for living on Moon and Mars, many questions still need to be resolved. Such habitation questions include prevention of and rehabilitation from negative effects of weightlessness that are, in many instances, comparable to problems of aging people on Earth as well as of patients during and recovery from long term stays in bed. Therefore the DLR Institute of Aerospace Medicine has designed a concept for a research facility that will make it possible to join space research directly with terrestrial applications. From a strategic point of view, one major emphasis of :envihab is to form a closely interrelated network of scientists and the industry and the public. The project has been in the planning phase for several years. After an international architectural contest, the winning concept was selected in 2007 by a Jury with ESA participation.
Collapse
|
64
|
Koch B, Wendt M, Lackner C, Ahnefeld FW. Herausforderungen an die Notfallversorgung der Zukunft: „Regional Health Care“ (RHC). Notf Rett Med 2008. [DOI: 10.1007/s10049-008-1065-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
65
|
Baldwin I, Bellomo R, Naka T, Koch B, Fealy N. A pilot randomized controlled comparison of extended daily dialysis with filtration and continuous veno-venous hemofiltration: fluid removal and hemodynamics. Int J Artif Organs 2008; 30:1083-9. [PMID: 18203070 DOI: 10.1177/039139880703001208] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
OBJECTIVES Extended intermittent dialytic techniques are increasingly being reported in the treatment of ARF in the ICU but few randomized controlled trials exist. We compared one such technique to a technique of continuous renal replacement therapy with regard to fluid removal and hemodynamics. METHODS Sixteen critically ill patients with ARF were enrolled in a randomized controlled trial at the ICU of a tertiary hospital. We randomized eight patients to three consecutive days of treatment with either Extended Daily Dialysis with filtration (EDDf) or Continuous Veno-Venous Hemofiltration (CVVH) and compared fluid removal and hemodynamics during treatment. RESULTS A total of 16.6 liters of fluid were removed during EDDf (830 mL/day over 20 treatment days) compared with 15.4 liters (700 ml/day over 22 treatment days) during CVVH. Median fluid removal per day was 1837 mL in the EDDf group compared with 1410 mL per day in the CVVH group, p=0.674. Median hourly fluid removal rate was 252 mL for EDDf and 128 mL for CVVH (p<0.01). Mean arterial pressure in the EDDf group was lower at two hours after starting treatment (76 mmHg vs. 94 mmHg) in the CVVH group; p= 0.031. There was no significant difference between groups for heart rate, CVP and noradrenaline dose at all time intervals measured. CONCLUSIONS Adequate prescribed fluid removal was achieved with both techniques. However, as expected, fluid was removed at a faster rate during EDDf. This was initially associated with a lower blood pressure than during CVVH where blood pressure increased.
Collapse
|
66
|
Koch B, Gläser S, Bollmann T, Spielhagen T, Ittermann T, Völzke H, Ewert R. Populationsbezogene Referenzwerte für die Spiroergometrie. Pneumologie 2008. [DOI: 10.1055/s-2008-1074220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
67
|
Koch B, Gläser S, Siegmund W, Heidecke C, Walther D, Ewert R. Tuberkulose – Persistierendes Fieber unter suffizienter antituberkulotischer Therapie. Pneumologie 2008. [DOI: 10.1055/s-2008-1074338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
68
|
Gläser S, Meyer R, Schäper C, Heinrich A, Koch B, Bollmann T, Warnke C, Walther D, Hetzer R, Ewert R. Histomorphologische pulmonal-interstitielle und -vaskuläre Veränderung als Ursache von Diffusionsstörungen nach Herztransplantation. Pneumologie 2008. [DOI: 10.1055/s-2008-1074404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
69
|
Schröder S, Walther D, Koch B, Warnke C, Gläser S. Ösophagobronchiale Fistel als seltene Ursache rezidivierender Pneumonien im Erwachsenenalter. Pneumologie 2008. [DOI: 10.1055/s-2008-1074305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
70
|
Gläser S, Noga O, Koch B, Schäper C, Schmitt B, Bollmann T, Opitz C, Ewert R. Fortgeschrittene interstitielle Lungenerkrankungen und pulmonale Hypertonie: Einfluss der pulmonal-arteriellen Hypertonie auf Gasaustausch, Atemeffizienz, Dyspnoe und Belastungsfähigkeit. Pneumologie 2008. [DOI: 10.1055/s-2008-1074130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
71
|
Bellebaum C, Koch B, Schwarz M, Daum I. Focal basal ganglia lesions are associated with impairments in reward-based reversal learning. Brain 2008; 131:829-41. [DOI: 10.1093/brain/awn011] [Citation(s) in RCA: 74] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
72
|
Ziegler D, Bongardt S, Koch B, Thierfelder S. Lacosamid: Klinische Untersuchungen zur Wirksamkeit und Verträglichkeit bei Patienten mit schmerzhafter diabetischer Neuropathie, Ergebnisse einer europäischen Doppelblindstudie. DIABETOL STOFFWECHS 2008. [DOI: 10.1055/s-2008-1076202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
73
|
Graf C, Jouck S, Koch B, Staudenmaier K, von Schlenk D, Predel HG, Tokarski W, Dordel S. Motorische Defizite – wie schwer wiegen sie? Monatsschr Kinderheilkd 2007. [DOI: 10.1007/s00112-007-1502-0] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
74
|
Bergholz R, Koch B, Lohse K, Steinhard J. Kurzzeitergebnisse nach Silastic-Silo versus Primärverschluss oder Patchversorgung bei Gastroschisis: Eine retrospektive Analyse. Geburtshilfe Frauenheilkd 2007. [DOI: 10.1055/s-2007-983689] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
75
|
Kleber M, Cybulla M, Bauchmüller K, Ihorst G, Koch B, Engelhardt M. Monitoring of renal function in cancer patients: an ongoing challenge for clinical practice. Ann Oncol 2007; 18:950-8. [PMID: 17351260 DOI: 10.1093/annonc/mdm055] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND Renal impairment (RI) has been shown to be one major risk factor in a number of diseases and is associated with a dismal clinical outcome. However, the influence of milder degrees of renal disease is less well defined, particularly not in patients with malignant diseases. PATIENTS AND METHODS We analyzed 167 patients with solid tumors and hematological malignancies. Besides disease-specific parameters, serum creatinine, cystatin C and the estimated glomerular filtration rate (eGFR) ['modification of diet in renal disease' equation (MDRD)/Cockcroft-Gault (CG)] were determined. Patients were compared within eGFR, creatinine and cystatin C groups. RESULTS The median MDRD, CG, creatinine and cystatin C levels of all patients were 88 ml/min/1.73 m2, 89 ml/min, 1 mg/dl and 0.9 mg/l, respectively. Patients with chronic kidney disease stage 2 still showed normal creatinine and cystatin levels of 1 mg/dl and 1.1 mg/l, respectively, although mild RI was frequent. Those cancer patients with decreased eGFR (MDRD) (<60 ml/min/1.73 m2) had increased odds ratios (ORs) to have more concurrent diagnoses [OR 3.4; 95% confidence interval (CI) 1.5-8.1], a body mass index >24 kg/m2 (OR 2.1; 95% CI 1.0-4.5) and an elevated (> 245 pg/ml) pro-brain natriuretic peptide level (proBNP) (OR 9.2; 95% CI 3.0-28.3). CONCLUSIONS These observations suggest that grouping cancer patients according to renal function, especially eGFR, may be one way to determine specific risk groups.
Collapse
|